The global End Stage Renal Disease (ESRD) Market size was worth USD 83.4 billion in 2022, with a projected compound annual growth rate of 3.5% during the forecast period. This growth is due to an increasing aging population and a rising prevalence of diabetes, hypertension, and Chronic Kidney Disorders (CKD), which are significant risk factors for ESRD. CKD affects over 37 million Americans and millions of others worldwide. Furthermore, an aging population that is more prone to developing chronic diseases such as CKD is expected to drive market revenue growth.

ESRD is the end stage of chronic renal disease, which occurs when the kidneys are no longer able to meet the body's rising demand. Dialysis or a kidney transplant is required for ESRD patients to survive. The prevalence of ESRD is expected to rise in the coming years due to an increasing aging population and the growing risk factors mentioned above.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/6278

Government programs designed to improve access to ESRD treatment could limit market revenue growth. For example, the Medicare End-Stage Renal Disease program in the United States covers dialysis and kidney transplantation for patients who qualify, and the Pradhan Mantri National Dialysis Program in India offers free dialysis services to patients in need.

Key players in the End Stage Renal Disease (ESRD) Market:

  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Asahi Kasei Corporation
  • Nikkiso Co. Ltd.
  • NxStage Medical, Inc.
  • Toray Industries, Inc.
  • Rockwell Medical, Inc.

However, the high cost of ESRD therapy, especially transplantation, and a lack of organ donors are factors that could restrain market revenue growth. Additionally, a lack of knowledge about CKD and ESRD in many parts of the world is another factor that could limit market revenue growth.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/6278

The global ESRD market is segmented into dialysis, kidney transplantation, and other treatments. Dialysis accounts for the largest revenue share due to its widespread availability, low cost, and high proportion of patients receiving dialysis. Kidney transplantation is expected to have a higher revenue growth rate during the forecast period because it can improve patients' quality of life more significantly than dialysis. However, the lack of appropriate donors and high costs of transplantation make it less accessible to a broad population.

The global ESRD market is segmented into blood tests, urine tests, imaging tests, and other diagnostic tools. Blood tests are the most commonly used diagnostic tool in the ESRD market and are expected to grow moderately fast during the forecast period. Urine tests account for a significant revenue share in the global ESRD market due to their ability to measure waste material levels in urine, including protein, which can indicate the kidneys' function.

In conclusion, the global ESRD market is expected to experience rapid revenue growth due to an increasing aging population and the growing prevalence of CKD, diabetes, and hypertension. However, government programs designed to improve access to treatment and the high cost of therapy and a lack of organ donors are factors that could restrain market revenue growth. The dialysis segment accounts for the largest revenue share in the market, while kidney transplantation is expected to have a higher revenue growth rate. Blood and urine tests are the most commonly used diagnostic tools in the ESRD market.

Request customization of the report @

https://www.reportsanddata.com/request-customization-form/6278

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

About Reports and Data 

 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies across relevant and fact-based research across industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We constantly update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact:

John W,  Head of Business Development
Reports And Data | Web:  www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail:  [email protected] LinkedIn  | Twitter  | Blogs